Rectal Diseases: Clinical Trials

8753 trials for Rectal Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3852 completed, 1677 unknown, 1275 recruiting, 702 terminated. 2454 Not applicable, 2433 Phase 2, 1500 Phase 1, 740 Phase 3, 169 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2454Completed 1126, Unknown 507, Recruiting 361, Not yet recruiting 153, Terminated 125, Active not recruiting 94, Withdrawn 57, Enrolling by invitation 21, Suspended 10
Phase 22433Completed 940, Unknown 443, Recruiting 358, Terminated 282, Active not recruiting 154, Not yet recruiting 133, Withdrawn 107, Suspended 13, Enrolling by invitation 3
Phase 11500Completed 651, Recruiting 257, Terminated 231, Unknown 139, Active not recruiting 109, Not yet recruiting 57, Withdrawn 46, Suspended 9, Enrolling by invitation 1
Phase 3740Completed 316, Unknown 174, Recruiting 99, Terminated 62, Active not recruiting 48, Not yet recruiting 25, Withdrawn 12, Suspended 3, Enrolling by invitation 1
Phase 4169Completed 87, Unknown 33, Not yet recruiting 12, Recruiting 12, Terminated 12, Withdrawn 9, Active not recruiting 4
Early Phase 177Unknown 20, Completed 19, Recruiting 13, Not yet recruiting 7, Terminated 6, Active not recruiting 5, Enrolling by invitation 3, Suspended 2, Withdrawn 2

Follow this condition Literature Review of Rectal Diseases trials Research Report on Rectal Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improving Clinic Delivery of HIV-related Anal Health Services
PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea
Not applicableNot yet recruitingAlbert Einstein College of Medicine82028-02-012026-10-13
The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp
Shared Decision Making using a Patient Decision Aid. - Shared Decision Making, Colonic Polyp
Phase 2Not yet recruitingVejle Hospital1102028-02-012026-04-30
CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Metastatic Colorectal Cancer
CA102N, TAS-102, Bevacizumab - Metastatic Colorectal Cancer
Phase 2SuspendedHoly Stone Healthcare Co., Ltd1002027-12-012026-09-18
Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer
intravoxel incoherent motion magnetic resonance imaging - Rectal Neoplasms, Prognosis
Not yet recruitingSichuan Cancer Hospital and Research Institute4002027-11-012025-12-08
Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
Balstilimab, Biopsy Procedure, Biospecimen Collection - Colorectal Adenocarcinoma, Stage II Colorectal Cancer AJCC v8
Phase 2RecruitingNational Cancer Institute (NCI)202027-05-252026-09-29
CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 1Not yet recruitingCity of Hope Medical Center362027-05-062026-09-25
Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options
Liver transplantation - Colorectal Neoplasms, Liver Neoplasms
Not applicableNot yet recruitingCharite University, Berlin, Germany2602027-04-012026-09-10
Life Expectancy-informed Colorectal Cancer Screening
Decision Tool - Colorectal Cancer Control and Prevention
Not applicableNot yet recruitingKathryn Martinez150002027-03-012026-10-20
A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
Dietary Fiber, Enema Administration, Loperamide Hydrochloride - Low Anterior Resection Syndrome, Rectal Carcinoma
Not applicableRecruitingOhio State University Comprehensive Cancer Center802027-02-152026-10-06
OSCAR II STUDY - The ONCObind CTC Removal Study
ONCObind (Onco-Seraph) 100 Filter, Matched Controls - Pancreatic Ductal Adenocarcinoma (mPDAC), Metastatic Colorectal Carcinoma (mCRC)
Not applicableNot yet recruitingExThera Medical Corporation1202027-01-152026-04-17
Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer
Aerobic Exercise, Biopsy Procedure, Biospecimen Collection - Colon Polyp, Colorectal Carcinoma
Not applicableRecruitingCity of Hope Medical Center302026-12-162026-08-28
A Study of DES-1357 in People With Deficient Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer (mCRC)
DES-1357 - Metastatic Colorectal Cancer (CRC)
Phase 1 / Phase 2Not yet recruitingD. E. Shaw Research, LLC882026-12-032026-09-08
COQ10 and Vitamin E for Off-Target Radiation Toxicity
Coenzyme Q10 Cap/Tab, Vitamin E Cap/Tab - Prostate Cancer, Uterine Cancer
Phase 1 / Phase 2Not yet recruitingUniversity of Nebraska2002026-12-012026-10-08
Preventing Early-Onset Colorectal Cancer in the VA
Patient intervention, PCP intervention - Colorectal Neoplasms, Mass Screening
Not applicableNot yet recruitingVA Office of Research and Development5362026-12-012026-10-02
Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer
Biospecimen Collection, Computed Tomography, Fluorouracil - Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Phase 1Not yet recruitingCity of Hope Medical Center302026-12-012026-09-02
A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation
LG00313112 - Ovarian Cancer, Small Cell Lung Cancer
Phase 1 / Phase 2Not yet recruitingLG Chem2502026-12-012026-08-07
Reducing Neoplasia Recurrence After Non-thermal Endoscopic Resection of Large Colorectal Polyps
Adjuvant thermal ablation, No adjuvant thermal ablation - Colorectal Cancer, Polyp of Colon
Not applicableNot yet recruitingCentre hospitalier de l'Université de Montréal (CHUM)7522026-12-012026-08-14
A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.
Signatera Genome ultra-sensitive ctDNA blood test - NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Cancer)
Not applicableNot yet recruitingNatera, Inc.9202026-12-012026-08-04
A Prospective Study to Evaluate the Diagnostic Accuracy of Computer-aided Diagnosis (CADx) System in Real-time Characterization of Colorectal Neoplasia
CADx - Colorectal Neoplasms
Not yet recruitingChinese University of Hong Kong5102026-12-012026-09-22
TCR1188-ABC Cells in KRAS-mutated Cancers
TCR1188-ABC cells, Fludarabine + Cyclophosphamide combination, Tocilizumab - Cholangiocarcinoma, Colorectal Cancer
Phase 1RecruitingUniversity of Pennsylvania302026-12-012026-10-14

Showing 20 of 8753. Sign in to see all of them.

Narrower conditions

Colorectal Neoplasms (6102)  ·  Rectal Neoplasms (2234)  ·  Colonic Neoplasms (1146)  ·  Breast Neoplasms (620)  ·  Neoplasms (527)  ·  Pancreatic Neoplasms (520)  ·  Carcinoma, Non-Small-Cell Lung (487)  ·  Stomach Neoplasms (460)  ·  Neoplasm Metastasis (458)  ·  Lung Neoplasms (369)  ·  Ovarian Neoplasms (339)  ·  Prostatic Neoplasms (311)  ·  Anus Neoplasms (294)  ·  Fecal Incontinence (278)  ·  Melanoma (263)

Broader conditions

Digestive System Diseases (8707)  ·  Gastrointestinal Diseases (8696)  ·  Intestinal Diseases (8692)  ·  Neoplasms by Site (7895)  ·  Digestive System Neoplasms (7871)  ·  Intestinal Neoplasms (7866)  ·  Gastrointestinal Neoplasms (7760)  ·  Neoplasms (7418)  ·  Colonic Diseases (6502)  ·  Colorectal Neoplasms (1829)  ·  Pathological Conditions, Signs and Symptoms (1821)  ·  Pathologic Processes (1133)  ·  Urogenital Diseases (1018)  ·  Neoplasms by Histologic Type (1000)

Interventions

Fluorouracil (644)  ·  Oxaliplatin (610)  ·  Bevacizumab (542)  ·  Leucovorin (522)  ·  Capecitabine (503)  ·  Irinotecan (468)  ·  Cetuximab (368)  ·  Radiotherapy (182)  ·  pembrolizumab (164)  ·  Folfox protocol (151)  ·  Panitumumab (127)  ·  Drug Therapy (120)  ·  regorafenib (114)  ·  Nivolumab (95)  ·  Colonoscopy (93)

Sponsors

National Cancer Institute (NCI) (179)  ·  Fudan University (135)  ·  Sun Yat-sen University (115)  ·  M.D. Anderson Cancer Center (112)  ·  Memorial Sloan Kettering Cancer Center (90)  ·  Hoffmann-La Roche (86)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (69)  ·  City of Hope Medical Center (59)  ·  Pfizer (51)  ·  Alliance for Clinical Trials in Oncology (50)  ·  Chinese University of Hong Kong (43)  ·  Assistance Publique - Hôpitaux de Paris (41)  ·  Massachusetts General Hospital (41)  ·  Amgen (40)  ·  Eli Lilly and Company (39)

Countries

United States (2907)  ·  China (1395)  ·  France (717)  ·  Spain (546)  ·  Italy (507)  ·  United Kingdom (479)  ·  Canada (436)  ·  Germany (409)  ·  South Korea (332)  ·  Belgium (299)  ·  Netherlands (296)  ·  Australia (256)  ·  Denmark (247)  ·  Sweden (205)  ·  Taiwan (194)

Top investigators

Norman Wolmark, MD (19)  ·  Ajay Goel, PhD (12)  ·  Marwan Fakih, MD (9)

Results publications

PMID 36306483, PMID 15496622, PMID 35588252, PMID 37162250, PMID 26049686, PMID 26187751, PMID 30679026, PMID 31378656, PMID 32816630, PMID 15933795, PMID 19269519, PMID 21596621, PMID 22070868, PMID 26808342, PMID 28712102, PMID 33657038, PMID 36748942, PMID 37310167, PMID 42681563, PMID 16971718, PMID 17976611, PMID 18316791, PMID 19339720, PMID 20106720, PMID 22067400, PMID 22529255, PMID 23008301, PMID 23395398, PMID 23493136, PMID 23578724, PMID 26156652, PMID 27432930, PMID 27602924, PMID 28223062, PMID 29627309, PMID 30025745, PMID 30207593, PMID 30451751, PMID 30936547, PMID 31268130, PMID 31401903, PMID 33439695, PMID 33538338, PMID 34213592, PMID 36064325, PMID 36410913, PMID 36606664, PMID 37934000, PMID 38592721, PMID 38861286

NIH funding

2023 (48), 2025 (44), 2017 (32), 2016 (30), 2009 (29), P30CA033572 (29), 2019 (28), 2015 (24), 2018 (24), P30CA015083 (22), 2008 (19), P30CA014089 (19), 2014 (17), P30CA016672 (15), P30CA068485 (14)